Xiaoyuan Chu
Nanjing University of Chinese Medicine(CN)Nanjing General Hospital of Nanjing Military Command(CN)Nanjing Traditional Chinese Medicine Hospital(CN)Second Affiliated Hospital of Nanjing Medical University(CN)Jining Medical University(CN)Nanjing Medical University(CN)Nanjing University(CN)
Publications by Year
Research Areas
Cancer-related molecular mechanisms research, MicroRNA in disease regulation, Circular RNAs in diseases, RNA modifications and cancer, Cancer Immunotherapy and Biomarkers
Most-Cited Works
- → New insights into the regulatory role of microRNA in tumor angiogenesis and clinical implications(2018)186 cited
- → Targeting KDM1A attenuates Wnt/β-catenin signaling pathway to eliminate sorafenib-resistant stem-like cells in hepatocellular carcinoma(2017)144 cited
- → The Emerging Roles of Long Noncoding RNA ROR (lincRNA-ROR) and its Possible Mechanisms in Human Cancers(2016)129 cited
- → Cancer-associated fibroblasts treated with cisplatin facilitates chemoresistance of lung adenocarcinoma through IL-11/IL-11R/STAT3 signaling pathway(2016)127 cited
- → A feed-forward loop between lncARSR and YAP activity promotes expansion of renal tumour-initiating cells(2016)111 cited
- → PU.1/microRNA-142-3p targets ATG5/ATG16L1 to inactivate autophagy and sensitize hepatocellular carcinoma cells to sorafenib(2018)108 cited